Health and Healthcare Systems

Should we rethink our views of ageing and dementia?

Image: A resident holds the hand of a nurse at the SenVital elderly home in Kleinmachnow outside Berlin. REUTERS/Thomas Peter.

Fabio Bergamin

We age because the cells in our bodies begin to malfunction over the years. This is the general view that scientists hold of the ageing process. For example, in older people the cells’ internal quality control breaks down. This control function usually eliminates proteins that have become unstable and lost their normal three-dimensional structure. These deformed proteins accumulate in the cells in a number of diseases, such as Parkinson's and Alzheimer's.

For Yves Barral, Professor of Biochemistry at ETH Zurich, the view of the ageing process as a consequence of flawed cell function and disease is too narrow. It ignores the fact that the mentioned so-called prion-like protein accumulations could have a positive effect, too, and therefore should not be referred to as cellular malfunction, he says.

Old cells cope better with stress

Barral drew this conclusion based on his research on yeast cells. He and his colleagues recently found in these cells a new type of protein aggregate, which appears as the cells get older. As the scientists were able to show, these protein aggregates do not arise as the result of a cell's malfunctioning internal quality control. On the contrary: in yeast cells with such aggregates, quality control functions even better. "It certainly seems that these aggregates help yeast cells to cope with the physiological changes caused by ageing," says Juha Saarikangas, a postdoc in Barral's group and first author of the recent study in the journal eLife. "We are very exited to learn what type of information is stored in these structures."

The scientists assume that these age-associated aggregates are formed by several different proteins. The researchers have already identified one prion-like protein that is part of the accumulations. What other proteins are involved and why the aggregates remain in the parent cells during cell division are subjects of further research.

Aggregates improve memory

Only in recent years have scientists speculated that aggregating proteins in the cells can generally play a positive role. Barral and his research group showed back in 2013 that yeast cells memorise experiences related to unsuccessful sexual reproduction attempts in the form of aggregated proteins (see ETH News [https://www.ethz.ch/en/news-and-events/eth-news/news/2013/12/protein-clumps-as-memory.html] from 05.12.2013). These aggregates – which are not identical to the newly discovered age-associated accumulations – thus serve as molecular memory for yeast cells. Even in mice there is a positive relationship between prion-like aggregates and memory. A few months ago, American scientists demonstrated that mice with such accumulations in their nerve cells exhibit a more stable long-term memory.

"Bad end to a good thing"

Whether such age-associated protein accumulations are primarily a malfunction or a normal function of healthy cells is for Barral a scientific question – one in which philosophy also plays a role: "Our western society understands ageing as something that is predominantly negative, a disease that has to be combated," he says. "This thinking is reflected in the work of many scientists, whose research on ageing focuses on finding defects in cells." Other societies, however, place more value on the positive effects of ageing, such as increased experience and knowledge – a view that corresponds with the newly discovered role of aggregates as information storage or memory for cells.

"We're still a fairly small group of scientists who say: aggregate proteins are not pathological – they are neither an accident nor a defect," says Barral. Rather, these proteins aggregate because it is their normal function. Diseases such as Parkinson's and Alzheimer's only arise when the system becomes imbalanced and too many prion-like proteins accumulate in the wrong place in the cells. Barral continues: "There are two aspects to ageing. Yes, you die at the end of the process, and this is negative. But you die wise. And Alzheimer's is perhaps a bad end to a good thing."

Don't miss any update on this topic

Create a free account and access your personalized content collection with our latest publications and analyses.

Sign up for free

License and Republishing

World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.

The views expressed in this article are those of the author alone and not the World Economic Forum.

Stay up to date:

Future of Global Health and Healthcare

Share:
The Big Picture
Explore and monitor how Ageing and Longevity is affecting economies, industries and global issues
A hand holding a looking glass by a lake
Crowdsource Innovation
Get involved with our crowdsourced digital platform to deliver impact at scale
World Economic Forum logo
Global Agenda

The Agenda Weekly

A weekly update of the most important issues driving the global agenda

Subscribe today

You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.

The key health achievements of COP29, and other top health stories

Shyam Bishen

November 20, 2024

How equitable access to medicines can drive sustainable returns for investors

About us

Engage with us

  • Sign in
  • Partner with us
  • Become a member
  • Sign up for our press releases
  • Subscribe to our newsletters
  • Contact us

Quick links

Language editions

Privacy Policy & Terms of Service

Sitemap

© 2024 World Economic Forum